Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -10.63M
December 31, 2025 -8.310M
June 30, 2025 -14.30M
December 31, 2024 -16.60M
June 30, 2024 -11.07M
December 31, 2023 -8.807M
June 30, 2023 -8.479M
December 31, 2022 -8.336M
June 30, 2022 -8.677M
December 31, 2021 -8.643M
June 30, 2021 -7.990M
Date Value
December 31, 2020 -12.46M
June 30, 2020 -11.72M
December 31, 2019 -8.598M
June 30, 2019 -12.99M
December 31, 2018 -18.49M
June 30, 2018 -16.33M
December 31, 2017 -19.14M
June 30, 2017 -20.30M
December 31, 2016 -18.29M
June 30, 2016 -23.27M
December 31, 2015 -20.25M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
NuCana Plc -6.612M
Mereo BioPharma Group Plc -25.58M
BioNTech SE 424.34M
Silence Therapeutics Plc -41.79M
Autolus Therapeutics Plc -240.12M

Free Cash Flow Related Metrics